Both Jefferies and Citi maintained a 'buy' rating on the stock, citing strong fundamentals and room for re-rating.

Barry Emerson, CFO, noted that gross profit for Q1 2025 was $54.3 million, compared to $60.4 million in the prior year, with a gross profit margin of 30.9%, slightly down from 31.2% in Q1 2024. The ...

Sage Therapeutics reported strong Q1 2025 growth, with ZURZUVAE leading the charge in postpartum depression treatment.

Strides Pharma Science said that its step-down wholly owned subsidiary in the US, Stride Pharma Inc, has acquired four approved ANDAs for the US Market from Nostrum Laboratories, Inc., USA.

As many as 22 important names like Vedanta, Indian Oil Corporation, Adani Power, Aeroflex Industries, Ajanta Pharma, Bandhan ...

Apart from the above Federal Bank, Forbes & Company, Go Fashion (India), Godrej Agrovet, Greaves Cotton, Orient Green Power ...

Nifty futures on the NSE International Exchange traded 68.80 points, or 0.28 per cent, higher at 24,356.50, hinting at a ...